Pharmaceutical Technology1 天
PF-07826390 by Pfizer for Solid Tumor: Likelihood of Approval
PF-07826390 is under development for the treatment of solid tumors including non-small cell lung cancer, colorectal cancer and renal cell carcinoma. It acts by targeting leukocyte immunoglobulin like ...
Pharmaceutical Technology1 天
PF-07826390 by Pfizer for Colorectal Cancer: Likelihood of Approval
PF-07826390 is under clinical development by Pfizer and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I drugs for Colorectal Cancer have a 75% phase transition success ...
How tariffs could hurt small businesses in New England
The tariffs are intended to encourage big companies to produce goods domestically but economists say the plan could be ...
vietnamagriculture.nongnghiep4 天
Businesses to show a stronger presence on e-commerce platforms
The Vietnamese trade counselor in the United States predicts a positive outlook for this market in early 2025 and recommends ...
StockNews.com Begins Coverage on China Jo-Jo Drugstores (NASDAQ:CJJD)
Equities researchers at StockNews.com began coverage on shares of China Jo-Jo Drugstores (NASDAQ:CJJD – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock ...